Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance -- HBSS
SAN FRANCISCO, Sept. 29, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows a...
Covered in this story
Call it yourself
No calls on $BBNX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Beta Bionics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.